Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Director departure Quarterly results
|
Durata Therapeutics, Inc. (DRTX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
11/19/2014 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
11/19/2014 |
4
| Canaan VIII LP (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc. |
11/19/2014 |
4
| Ahrens Brenton Karl (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Unknown transaction of 1,902,030 shares
@ $0 Disposed/sold 5,034 shares
@ $0 Disposed/sold 1,216 options to buy
@ $0 Disposed/sold 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
11/19/2014 |
4
| Canaan VIII LP (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Exercised 6,250 options to buy
@ $2.08, valued at
$13k
Exercised 1,216 restricted stock units
@ $0 |
|
11/19/2014 |
4
| Ahrens Brenton Karl (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Exercised 6,250 options to buy
@ $2.08, valued at
$13k
Exercised 1,216 restricted stock units
@ $0 |
|
11/19/2014 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Durata Therapeutics, Inc. |
11/19/2014 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 11,145 options to buy
@ $7.16, valued at
$79.8k
Disposed/sold 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
11/19/2014 |
4
| DE SCHUTTER RICHARD U (Director) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 15,000 shares
@ $0 Disposed/sold 12,500 shares
@ $0 Disposed/sold 4,375 options to buy
@ $10, valued at
$43.8k
Disposed/sold 1,250 options to buy
@ $7.16, valued at
$9k
Disposed/sold 1,876 options to buy
@ $7.16, valued at
$13.4k
Disposed/sold 14,489 options to buy
@ $7.16, valued at
$103.7k
Disposed/sold 10,290 options to buy
@ $16.15, valued at
$166.2k
|
|
11/18/2014 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 5,000 shares
@ $0 Disposed/sold 6,250 options to buy
@ $10, valued at
$62.5k
Disposed/sold 1,875 options to buy
@ $10, valued at
$18.8k
Disposed/sold 1,875 options to buy
@ $7.16, valued at
$13.4k
Disposed/sold 2,813 options to buy
@ $7.16, valued at
$20.1k
Disposed/sold 11,145 options to buy
@ $7.16, valued at
$79.8k
Disposed/sold 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
11/18/2014 |
4
| Fishman Corey N. (CFO&COO) has filed a Form 4 on Durata Therapeutics, Inc. |
11/18/2014 |
4
| CARROLL J MARTIN (Director) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 8,134 options to buy
@ $16.77, valued at
$136.4k
|
|
11/18/2014 |
4
| YARNO WENDY L (Director) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 8,134 options to buy
@ $16.77, valued at
$136.4k
|
|
11/18/2014 |
4
| Shannon John Patrick Jr (Chief Commercial Officer) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 11,000 shares
@ $0 Disposed/sold 93,750 options to buy
@ $2.08, valued at
$195k
Disposed/sold 20,000 options to buy
@ $7.49, valued at
$149.8k
Disposed/sold 75,000 options to buy
@ $16.15, valued at
$1.2M
|
|
11/18/2014 |
4
| Edick Paul R (CEO) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 45,636 shares
@ $0 Disposed/sold 500 shares
@ $0 Disposed/sold 656,250 options to buy
@ $0.96, valued at
$630k
Disposed/sold 42,234 options to buy
@ $10, valued at
$422.3k
Disposed/sold 12,500 options to buy
@ $10, valued at
$125k
Disposed/sold 100,000 options to buy
@ $7.49, valued at
$749k
Disposed/sold 300,000 options to buy
@ $16.15, valued at
$4.8M
|
|
11/18/2014 |
4
| Dunne Michael W. (Chief Medical Officer) has filed a Form 4 on Durata Therapeutics, Inc. |
11/18/2014 |
4
| New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 3,028,439 shares
@ $0 |
|
11/18/2014 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 3,006,132 shares
@ $0 |
|
11/18/2014 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 22,306 shares
@ $0 |
|
11/18/2014 |
4
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 6,250 shares
@ $0 |
|
11/18/2014 |
4
| VITULLO NICOLE (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Disposed/sold 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
08/28/2014 |
4
| CARROLL J MARTIN (Director) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Granted 8,134 options to buy
@ $16.77, valued at
$136.4k
|
|
08/28/2014 |
4
| YARNO WENDY L (Director) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Granted 8,134 options to buy
@ $16.77, valued at
$136.4k
|
|
08/13/2014 |
4
| Shannon John Patrick Jr (Chief Commercial Officer) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Bought 3,000 shares
@ $13.72, valued at
$41.2k
|
|
06/13/2014 |
4
| Edick Paul R (CEO) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Bought 3,000 shares
@ $15.23, valued at
$45.7k
|
|
05/23/2014 |
4
| Canaan VIII LP (Director) has filed a Form 4 on Durata Therapeutics, Inc. |
05/23/2014 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Granted 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
05/23/2014 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Granted 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
05/23/2014 |
4
| HUNT RONALD (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Granted 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
05/23/2014 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Granted 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
05/22/2014 |
4
| VITULLO NICOLE (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Granted 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
05/22/2014 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Durata Therapeutics, Inc. |
05/22/2014 |
4
| DE SCHUTTER RICHARD U (Director) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Granted 10,290 options to buy
@ $16.15, valued at
$166.2k
|
|
05/22/2014 |
4
| Fishman Corey N. (CFO & COO) has filed a Form 4 on Durata Therapeutics, Inc. |
05/22/2014 |
4
| Edick Paul R (CEO) has filed a Form 4 on Durata Therapeutics, Inc.
Txns:
| Granted 300,000 options to buy
@ $16.15, valued at
$4.8M
|
|
|
|
|